On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice

Background and aims: Tamoxifen (TMX) has proven to be an effective palliative treatment for advanced breast cancer with low reported incidence of side effects. TMX has been demonstrated to be an initiator and/or a promoter in the rat model of hepatocarcinogenesis. To document the long-term effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerez, Esther Noemí, Batlle, Alcira María del Carmen, Vázquez, Elba Susana
Publicado: 2001
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13572725_v33_n7_p681_Caballero
http://hdl.handle.net/20.500.12110/paper_13572725_v33_n7_p681_Caballero
Aporte de:
id paper:paper_13572725_v33_n7_p681_Caballero
record_format dspace
spelling paper:paper_13572725_v33_n7_p681_Caballero2023-06-08T16:11:16Z On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice Gerez, Esther Noemí Batlle, Alcira María del Carmen Vázquez, Elba Susana Cytochrome P450 Hepatocarcinogenesis Oxidative stress P-Dimethylaminoazobenzene Tamoxifen 4 dimethylaminoazobenzene antineoplastic agent catalase cytochrome P450 glutathione transferase liver enzyme superoxide dismutase tamoxifen tamoxifen citrate animal experiment animal model animal tissue article controlled study degradation diet enzyme activity heme synthesis liver carcinogenesis liver cell carcinoma liver hyperplasia liver injury liver tumor long term care male mouse nonhuman oxidative stress response time 5-Aminolevulinate Synthetase Animals Body Weight Carcinogens Catalase Cytochrome P-450 Enzyme System Glutathione Transferase Heme Oxygenase (Decyclizing) Liver Liver Neoplasms, Experimental Male Mice Organ Size p-Dimethylaminoazobenzene Superoxide Dismutase Tamoxifen Thiobarbituric Acid Reactive Substances Time Factors Animalia Background and aims: Tamoxifen (TMX) has proven to be an effective palliative treatment for advanced breast cancer with low reported incidence of side effects. TMX has been demonstrated to be an initiator and/or a promoter in the rat model of hepatocarcinogenesis. To document the long-term effect of TMX in mice treated with p-dimethylaminoazobenzene (DAB), we have investigated the time response action of these drugs on different biochemical parameters. Methods: A group of animals was placed on dietary DAB (0.5%, w/w) during a period of 28 weeks. Control animals received a standard laboratory diet. Two other groups of non-treated and DAB-treated animals received TMX citrate (0.025%, w/w) in the diet since day 20. Results: The activities of the enzymes involved in heme synthesis and degradation as evaluated in the DAB group was not further affected by TMX. DAB and/or TMX treatment significantly increased the content of total cytochrome P450 and also the activity of glutathione S-transferase indicating liver damage. In all treated groups oxidative stress and an adaptive response of the natural defense system (catalase and superoxide dismutase) were demonstrated. Histological and morphological studies revealed liver cell hyperplasia in DAB treated group; however, only in the DAB+TMX group solid, trabecular and acinar hepatocellular carcinoma was confirmed at the end of the experimental trial. Conclusion: We have demonstrated that TMX produced changes in hepatic enzyme activities which may be relevant for the metabolism and disposition of this and/or other drugs. Because liver tumors could be initiated and promoted by several agents which need to be activated, the possible hazard of TMX should be considered. This study reports that long-term treatment with TMX enhances hepatocarcinogenesis induced by DAB. The widespread use of TMX as an anticancer agent adds to the significance of this study. © 2001 Published by Elsevier Science Ltd. Fil:Gerez, E. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Batlle, A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Vazquez, E. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2001 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13572725_v33_n7_p681_Caballero http://hdl.handle.net/20.500.12110/paper_13572725_v33_n7_p681_Caballero
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Cytochrome P450
Hepatocarcinogenesis
Oxidative stress
P-Dimethylaminoazobenzene
Tamoxifen
4 dimethylaminoazobenzene
antineoplastic agent
catalase
cytochrome P450
glutathione transferase
liver enzyme
superoxide dismutase
tamoxifen
tamoxifen citrate
animal experiment
animal model
animal tissue
article
controlled study
degradation
diet
enzyme activity
heme synthesis
liver carcinogenesis
liver cell carcinoma
liver hyperplasia
liver injury
liver tumor
long term care
male
mouse
nonhuman
oxidative stress
response time
5-Aminolevulinate Synthetase
Animals
Body Weight
Carcinogens
Catalase
Cytochrome P-450 Enzyme System
Glutathione Transferase
Heme Oxygenase (Decyclizing)
Liver
Liver Neoplasms, Experimental
Male
Mice
Organ Size
p-Dimethylaminoazobenzene
Superoxide Dismutase
Tamoxifen
Thiobarbituric Acid Reactive Substances
Time Factors
Animalia
spellingShingle Cytochrome P450
Hepatocarcinogenesis
Oxidative stress
P-Dimethylaminoazobenzene
Tamoxifen
4 dimethylaminoazobenzene
antineoplastic agent
catalase
cytochrome P450
glutathione transferase
liver enzyme
superoxide dismutase
tamoxifen
tamoxifen citrate
animal experiment
animal model
animal tissue
article
controlled study
degradation
diet
enzyme activity
heme synthesis
liver carcinogenesis
liver cell carcinoma
liver hyperplasia
liver injury
liver tumor
long term care
male
mouse
nonhuman
oxidative stress
response time
5-Aminolevulinate Synthetase
Animals
Body Weight
Carcinogens
Catalase
Cytochrome P-450 Enzyme System
Glutathione Transferase
Heme Oxygenase (Decyclizing)
Liver
Liver Neoplasms, Experimental
Male
Mice
Organ Size
p-Dimethylaminoazobenzene
Superoxide Dismutase
Tamoxifen
Thiobarbituric Acid Reactive Substances
Time Factors
Animalia
Gerez, Esther Noemí
Batlle, Alcira María del Carmen
Vázquez, Elba Susana
On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice
topic_facet Cytochrome P450
Hepatocarcinogenesis
Oxidative stress
P-Dimethylaminoazobenzene
Tamoxifen
4 dimethylaminoazobenzene
antineoplastic agent
catalase
cytochrome P450
glutathione transferase
liver enzyme
superoxide dismutase
tamoxifen
tamoxifen citrate
animal experiment
animal model
animal tissue
article
controlled study
degradation
diet
enzyme activity
heme synthesis
liver carcinogenesis
liver cell carcinoma
liver hyperplasia
liver injury
liver tumor
long term care
male
mouse
nonhuman
oxidative stress
response time
5-Aminolevulinate Synthetase
Animals
Body Weight
Carcinogens
Catalase
Cytochrome P-450 Enzyme System
Glutathione Transferase
Heme Oxygenase (Decyclizing)
Liver
Liver Neoplasms, Experimental
Male
Mice
Organ Size
p-Dimethylaminoazobenzene
Superoxide Dismutase
Tamoxifen
Thiobarbituric Acid Reactive Substances
Time Factors
Animalia
description Background and aims: Tamoxifen (TMX) has proven to be an effective palliative treatment for advanced breast cancer with low reported incidence of side effects. TMX has been demonstrated to be an initiator and/or a promoter in the rat model of hepatocarcinogenesis. To document the long-term effect of TMX in mice treated with p-dimethylaminoazobenzene (DAB), we have investigated the time response action of these drugs on different biochemical parameters. Methods: A group of animals was placed on dietary DAB (0.5%, w/w) during a period of 28 weeks. Control animals received a standard laboratory diet. Two other groups of non-treated and DAB-treated animals received TMX citrate (0.025%, w/w) in the diet since day 20. Results: The activities of the enzymes involved in heme synthesis and degradation as evaluated in the DAB group was not further affected by TMX. DAB and/or TMX treatment significantly increased the content of total cytochrome P450 and also the activity of glutathione S-transferase indicating liver damage. In all treated groups oxidative stress and an adaptive response of the natural defense system (catalase and superoxide dismutase) were demonstrated. Histological and morphological studies revealed liver cell hyperplasia in DAB treated group; however, only in the DAB+TMX group solid, trabecular and acinar hepatocellular carcinoma was confirmed at the end of the experimental trial. Conclusion: We have demonstrated that TMX produced changes in hepatic enzyme activities which may be relevant for the metabolism and disposition of this and/or other drugs. Because liver tumors could be initiated and promoted by several agents which need to be activated, the possible hazard of TMX should be considered. This study reports that long-term treatment with TMX enhances hepatocarcinogenesis induced by DAB. The widespread use of TMX as an anticancer agent adds to the significance of this study. © 2001 Published by Elsevier Science Ltd.
author Gerez, Esther Noemí
Batlle, Alcira María del Carmen
Vázquez, Elba Susana
author_facet Gerez, Esther Noemí
Batlle, Alcira María del Carmen
Vázquez, Elba Susana
author_sort Gerez, Esther Noemí
title On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice
title_short On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice
title_full On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice
title_fullStr On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice
title_full_unstemmed On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice
title_sort on the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in cf1 mice
publishDate 2001
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13572725_v33_n7_p681_Caballero
http://hdl.handle.net/20.500.12110/paper_13572725_v33_n7_p681_Caballero
work_keys_str_mv AT gerezesthernoemi onthepromotingactionoftamoxifeninamodelofhepatocarcinogenesisinducedbypdimethylaminoazobenzeneincf1mice
AT batllealciramariadelcarmen onthepromotingactionoftamoxifeninamodelofhepatocarcinogenesisinducedbypdimethylaminoazobenzeneincf1mice
AT vazquezelbasusana onthepromotingactionoftamoxifeninamodelofhepatocarcinogenesisinducedbypdimethylaminoazobenzeneincf1mice
_version_ 1768544332787220480